Cancel
Erick Gamelin
Chief Development Officer
@
Acrivon Therapeutics
5xz5uq4d@h82y5tq.1uz
Sign up to see email
See Linkedin
Known information
- Has 30 years of academic and industry leadership experience.
- Previously served as Chief Medical Officer at STEP Pharma.
- Held senior clinical roles at Amgen, Pfizer, Dynavax, and Macrogenics.
- Formerly CEO of The West Oncology Institute, a national university cancer center and hospital.
- Led over 150 phase 1-3 oncology trials.
- Awarded the title of 'Chevalier in the National Order of Merit' by the French Minister of Health.
- Medical Oncologist and Pharmacologist.
- Former Professor of Oncology.
- Led a research lab in oncogenomics and genetics funded by the French NCI.
- Focused on mechanisms of acquired resistance of cancer cells.
- Received a Ph.D. in molecular pharmacology from Bordeaux University.
- Completed a Post-Doc at the NIH, Molecular Therapeutics Section, Medical Oncology Branch.
- Coauthored more than 135 articles in peer-reviewed international journals.
About Acrivon Therapeutics
Acrivon Therapeutics develops precision oncology medicines using a proprietary proteomics-based platform, with its lead candidate ACR-368 in a Phase 2 trial for multiple tumor types.
Report inaccurate information